Redefining druggable targets with artificial intelligence

Affiliations

• ¹ Schrödinger, New York, NY, USA.
• ² Department of Systems Biology, Columbia University, New York, NY, USA.
• ³ Dewpoint Therapeutics, Boston, MA, USA.
• ⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁵ Harmonic Discovery, New York, NY, USA.
• ⁶ Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁷ Amgen, Cambridge, MA, USA.
• ⁸ Khoury College of Computer Science, Northeastern University, Boston, MA, USA.
• ⁹ National Cancer Institute, Bethesda, MD, USA.
• ¹⁰ University of California San Francisco, San Francisco, CA, USA.
• ¹¹ Genesis Therapeutics, Burlington, CA, USA.
• ¹² University of Maryland, College Park, MD, USA.
• ¹³ Institute for Protein Design, Seattle, WA, USA.
• ¹⁴ Oak Ridge National Laboratory, Oak Ridge, TN, USA.
• ¹⁵ Stanford University, Stanford, CA, USA.
• ¹⁶ Massachusetts Institute of Technology, Cambridge, MA, USA. regina@csail.mit.edu.
• ¹⁷ Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. ole2001@med.cornell.edu.